 |
nivolumab |
|---|---|
| Trade Name | Opdivo(R) |
| Orphan Indication | Hepatocellular Carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2015-09-02 00:00:00 |
| Sponsor | Bristol-Myers Squibb Company;P. O. Box 4000;Princeton, New Jersey, 08543 |
| |
nivolumab |
|---|---|
| Trade Name | Opdivo(R) |
| Orphan Indication | Hepatocellular Carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2015-09-02 00:00:00 |
| Sponsor | Bristol-Myers Squibb Company;P. O. Box 4000;Princeton, New Jersey, 08543 |